Cited by 468HIV Research and TreatmentVirus-based gene therapy researchGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

Open access

Jordan, Albert, Defechereux, Patricia, Verdin, Eric·2001·The EMBO Journal

DOI 10.1093/emboj/20.7.1726PMC PMC145503

Open this paper in CoChat — free account Open PDF

Abstract

Because of the heterogeneity of chromatin, the site of integration of human immunodeficiency virus (HIV) in the genome could have dramatic effects on its transcriptional activity. We have used an HIV-1-derived retroviral vector, in which the green fluorescent protein is under the control of the HIV promoter, to generate by infection 34 Jurkat clonal cell lines each containing a single integration of the HIV-1 vector. In the absence of Tat, a 75-fold difference in expression level between the highest and lowest expressing clones was observed. Basal promoter activity was low in 80% of the clones and moderate to high in the remaining 20% of clones. We found that differences in expression levels are due to the integration site and are not controlled by DNA methylation or histone acetylation. Tat activated transcription in each clone, and an inverse correlation was observed between basal transcriptional activity and inducibility by Tat. These observations demonstrate that the chromatin environment influences basal HIV gene expression and that the HIV Tat protein activates transcription independently of the chromatin environment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/emboj/20.7.1726

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Dissecting the regulatory circuitry of a eukaryotic genome
Holstege, F. C. P., Jennings, E. G., Wyrick, J. J., Lee, T. I., Hengartner, C. J., Green, M. R., Golub, T. R., Lander, E. S., & Young, R. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81641-4 · Cited by 1,670
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory, D., Neugeboren, B. I., & Mulligan, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11400 · Cited by 926
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
Kao, S.-Y., Calman, A. F., Luciw, P. A., & Peterlin, B. M. (1987) · Nature · doi:10.1038/330489a0 · Cited by 908
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
Zennou, V., Petit, C., Guétard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 864
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition
Miller, M. D., Farnet, C. M., & Bushman, F. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5382-5390.1997 · Cited by 620
Transcriptional activation and chromatin remodeling of the HIV‐1 promoter in response to histone acetylation.
Lint, C. M. V., Emiliani, S., Ott, M., & Verdin, E. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00449.x · Cited by 579
Self-citation
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitroPreprint
Mancebo, H. S. Y., Lee, G., Flygare, J. A., Tomassini, J. E., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D. J., Price, D. H., et al. (1997) · Genes & Development · doi:10.1101/gad.11.20.2633 · Cited by 546
Binding and Stimulation of HIV-1 Integrase by a Human Homolog of Yeast Transcription Factor SNF5
Kalpana, G. V., Marmon, S., Wang, W., Crabtree, G. R., & Goff, S. P. (1994) · Science · doi:10.1126/science.7801128 · Cited by 530
Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.
Verdin, E. M., Paras, P., & Lint, C. M. V. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05994.x · Cited by 520
Self-citation

Show all 48 references

Sorted by citations

Items 301–400 of 468

Dynamical Regulation of mRNA Distribution by Cross-Talking Signaling Pathways
Zhu, C., Han, G., & Jiao, F. (2020) · Complexity · doi:10.1155/2020/6402703 · Cited by 13
Identification of RFPL3 Protein as a Novel E3 Ubiquitin Ligase Modulating the Integration Activity of Human Immunodeficiency Virus, Type 1 Preintegration Complex Using a Microtiter Plate-based Assay
Tan, B. H., Suzuki, Y., Takahashi, H., Ying, P. H. R., Takahashi, C., Han, Q., Chin, W. X., Chao, S., Sawasaki, T., Yamamoto, N., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561662 · Cited by 13
Viral Determinants of Integration Site Preferences of Simian Immunodeficiency Virus-Based Vectors
Monse, H., Laufs, S., Kuate, S., Zeller, W. J., Früehauf, S., & Überla, K. (2006) · Journal of Virology · doi:10.1128/jvi.00373-06 · Cited by 13
Proviruses with Long-Term Stable Expression Accumulate in Transcriptionally Active Chromatin Close to the Gene Regulatory Elements: Comparison of ASLV-, HIV- and MLV-Derived Vectors
Miklík, D., Šenigl, F., & Hejnar, J. (2018) · Viruses · doi:10.3390/v10030116 · Cited by 13
Dynamics of a new HIV model with the activation status of infected cells
Guo, T., Qiu, Z., Shen, M., & Rong, L. (2021) · Journal of Mathematical Biology · doi:10.1007/s00285-021-01604-3 · Cited by 12
CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells
Horvath, R. M., & Sadowski, I. (2024) · iScience · doi:10.1016/j.isci.2024.111244 · Cited by 14
Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal
Martínez‐Bonet, M., Clemente, M. I., Álvarez, S., Díaz, L., García-Alonso, D., Muñóz, E., Moreno, S., & Muñoz‐Fernández, M. Á. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.09.014 · Cited by 12
The Synthetic Opioid Fentanyl Increases HIV Replication and Chemokine Co-Receptor Expression in Lymphocyte Cell Lines
Krishnan, J. M., Kong, L. X., Karns, R. A., Medvedovic, M., Sherman, K. E., & Blackard, J. T. (2023) · Viruses · doi:10.3390/v15041027 · Cited by 12
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines
Turrini, F., Saliu, F., Forlani, G., Das, A. T., Lint, C. M. V., Accolla, R. S., Berkhout, B., Poli, G., & Vicenzi, E. (2019) · Virus Research · doi:10.1016/j.virusres.2019.05.009 · Cited by 12
A Genomic and Bioinformatics Analysis of the Integration of HIV in Peripheral Blood Mononuclear Cells
Soto, M. J., Peña, Á., & Vallejo, F. G. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0182 · Cited by 12
Transient Thresholding: A Mechanism Enabling Noncooperative Transcriptional Circuitry to Form a Switch
Aull, K. H., Tanner, E. J., Thomson, M., & Weinberger, L. S. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.05.002 · Cited by 11
Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors
Perdigão, P. R. L., Gaj, T., Santa‐Marta, M., Barbas, C. F., & Gonçalves, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150037 · Cited by 11
FoxO4 negatively controls Tat-mediated HIV-1 transcription through the post-transcriptional suppression of Tat encoding mRNA
Oteiza, A., & Mechti, N. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000837 · Cited by 11
An IRES-Mediated Tricistronic Vector for Efficient Generation of Stable, High-Level Monoclonal Antibody Producing CHO DG44 Cell Lines
Yeo, J. H. M., Mariati, & Yang, Y. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8648-4_17 · Cited by 11
Using average transcription level to understand the regulation of stochastic gene activation
Chen, L., Lin, G., & Jiao, F. (2022) · Royal Society Open Science · doi:10.1098/rsos.211757 · Cited by 11
Integration of HIV in the Human Genome: Which Sites Are Preferential? A Genetic and Statistical Assessment
Gonçalves, J., Moreira, E., Sequeira, I. J., Rodrigues, A. S., Rueff, J., & Brás, A. (2016) · International Journal of Genomics · doi:10.1155/2016/2168590 · Cited by 11
Latent HIV-1 TAR Regulates 7SK-Responsive P-TEFb Target Genes and Targets Cellular Immune Responses in the Absence of Tat
Eilebrecht, S., Benecke, B., & Benecke, A. (2017) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2017.05.003 · Cited by 11
The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells
Pan, H., Lu, P., Shen, Y., Wang, Y., Jiang, Z., Yang, X., Zhong, Y., Yang, H. B., Khan, I. U., Zhou, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21585 · Cited by 11
Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets
Raines, S. L. M., Falcinelli, S. D., Peterson, J. J., Gulck, E. R. V., Allard, B., Kirchherr, J., Vega, J. B., Nájera, I., Boden, D., Archin, N. M., et al. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00201-24 · Cited by 10
Heterogeneity of HIV-1 latent reservoirs
Zhao, J., & Deng, K. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001085 · Cited by 11
Targeting Epigenetics to Cure HIV-1: Lessons From (and for) Cancer Treatment
Svensson, J. P. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668637 · Cited by 9
Transcriptional repression in stochastic gene expression, patterning, and cell fate specification
Voortman, L., & Johnston, R. J. (2021) · Developmental Biology · doi:10.1016/j.ydbio.2021.10.002 · Cited by 10
HIV-1 transcriptional modulation: novel host factors and prospective therapeutic strategies
Gibaut, Q. M. R., Mori, L., & Valente, S. T. (2023) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000808 · Cited by 11
Noncanonical-NF-κB activation and DDX3 inhibition reduces the HIV-1 reservoir by elimination of latently infected cells ex-vivo
Jansen, J., Kroeze, S., Man, S., Andreini, M., Bakker, J.-W., Zamperini, C., Tarditi, A., Kootstra, N. A., & Geijtenbeek, T. B. H. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03180-23 · Cited by 10
BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells
Turner, A. W., Bashore, F. M., Falcinelli, S. D., Fox, J. A., Keller, A. L., Fenton, A. D., Geyer, R. F., Allard, B., Kirchherr, J., Archin, N. M., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01777-24 · Cited by 10
Effects of heme degradation products on reactivation of latent HIV-1
Shankaran, P., Madlenakova, M., Hajkova, V., Jilich, D., Svobodová, I., Hořínek, A., Fujikura, Y., & Mělková, Z. (2017) · Acta Virologica · doi:10.4149/av_2017_01_86 · Cited by 10
The Per-1 Short Isoform Inhibits de novo HIV-1 Transcription in Resting CD4+ T-cells
Zhao, L., Liu, M., Ouyang, J., Zhu, Z., Geng, W., Dong, J., Xiong, Y., Wang, S., Zhang, X., Qiao, Y., et al. (2019) · Current HIV Research · doi:10.2174/1570162x17666190218145048 · Cited by 9
Predicting Post-treatment HIV Remission: Does Size of the Viral Reservoir Matter?
Pasternak, A. O., Psomas, C. K., & Berkhout, B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.648434 · Cited by 10
Genetically intact but functionally impaired HIV-1 env glycoproteins in the T-cell reservoir
de Verneuil, A., Migraine, J., Mammano, F., Molina, J.-M., Gallien, S., Mouquet, H., Hance, A. J., Clavel, F., & Dutrieux, J. (2018) · Journal of Virology · doi:10.1128/jvi.01684-17 · Cited by 10
Distribution of HIV-1 in the genomes of AIDS patients
Tsyba, L. O., Rynditch, A. V., Boeri, E., Jabbari, K., & Bernardi, G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3436-6 · Cited by 10
The Complex Interactions Between HIV-1 and Human Host Cell Genome: From Molecular Mechanisms to Clinical Practice
Tolomeo, M., Tolomeo, F., & Cascio, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073184 · Cited by 10
Retroviral Vector Technology for Gene Therapy: History, Current Landscape, and Future Prospects
Jaballah, S. A., Ali, L. M., Jehad, M. A., Akhlaq, S., Rizvi, T. A., & Mustafa, F. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169473 · Cited by 10
A Lentiviral Vector That Activates Latent Human Immunodeficiency Virus-1 Proviruses by the Overexpression of Tat and That Kills the Infected Cells
Macías, D., Oya, R., Saniger, L., Martı́n, F., & Luque, F. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.059 · Cited by 9
HIV-Tocky system to visualize proviral expression dynamics
Reda, O., Monde, K., Sugata, K., Rahman, A., Sakhor, W., Rajib, S. A., Sithi, S. N., Tan, B. J. Y., Niimura, K., Motozono, C., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06025-8 · Cited by 10
A transcriptional cycling model recapitulates chromatin-dependent features of noisy inducible transcription
Bullock, M. E., Moreno-Martinez, N., & Miller‐Jensen, K. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010152 · Cited by 9
A Camptothetin Analog, Topotecan, Promotes HIV Latency via Interference with HIV Transcription and RNA Splicing
Mukim, A., Smith, D. M., Deshmukh, S., Qazi, A. A., & Beliakova‐Bethell, N. (2023) · Journal of Virology · doi:10.1128/jvi.01630-22 · Cited by 9
HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro
Moso, M. A., Anderson, J. L., Adikari, S., Gray, L. R., Khoury, G., Chang, J. J., Jacobson, J. C., Ellett, A. M., Cheng, W., Saleh, S. M., et al. (2018) · AIDS · doi:10.1097/qad.0000000000002075 · Cited by 9
Mathematical modeling and mechanisms of HIV latency for personalized anti latency therapies
Rasi, G., Emili, E., Conway, J. M., Cotugno, N., & Palma, P. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00538-6 · Cited by 8
PADI4-mediated citrullination of histone H3 stimulates HIV-1 transcription
Love, L., Jütte, B. B., Lindqvist, B., Rohdjess, H., Kieri, O., Nowak, P., & Svensson, J. P. (2025) · Nature Communications · doi:10.1038/s41467-025-61029-0 · Cited by 8
Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variation
Inderbitzin, A., Loosli, T., Kouyos, R. D., & Metzner, K. J. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.06.003 · Cited by 9
Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV—Based Vectors and for a Cure for HIV-1 Infection
Pellaers, E., Bhat, A., Christ, F., & Debyser, Z. (2022) · Viruses · doi:10.3390/v15010032 · Cited by 8
Antibody-Free Glycogen Nanoparticles Engage Human Immune T Cells for Intracellular Delivery of Small Drugs or mRNA
Fernandes, S., Quattrociocchi, M., Cassani, M., Savazzi, G., Johnson, D. N., Forte, G., Caruso, F., & Cavalieri, F. (2024) · ACS Nano · doi:10.1021/acsnano.4c09156 · Cited by 8
HIV-1-Tat potentiates CXCL12/Stromal Cell-Derived Factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through Protein kinase C zeta
Hidalgo-Estévez, A. M., Punzón, C., Sánchez‐Duffhues, G., Muñóz, E., & Fresno, M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.004 · Cited by 8
A versatile plasmid architecture for mammalian synthetic biology (VAMSyB)
Haellman, V., Strittmatter, T., Bertschi, A., Stücheli, P., & Fussenegger, M. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.04.003 · Cited by 9
G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential
Ajoge, H. O., Kohio, H. P., Paparisto, E., Coleman, M. D., Wong, K., Tom, S. K., Bain, K. L., Berry, C. C., Arts, E. J., & Barr, S. D. (2022) · Viruses · doi:10.3390/v14112494 · Cited by 10
Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure
Brumme, Z. L., Chopera, D., & Brockman, M. A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.08.003 · Cited by 8
Histone Deacetylase Inhibitor MC1293 Induces Latent HIV-1 Reactivation by Histone Modification In Vitro Latency Cell Lines
Qu, X., Ying, H., Wang, X., Kong, C., Zhou, X., Wang, P., & Zhu, H. (2013) · Current HIV Research · doi:10.2174/157016213804999249 · Cited by 8
The Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV?
Schaller, T., & Herold, N. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094914 · Cited by 8
The 73 kDa Subunit of the CPSF Complex Binds to the HIV-1 LTR Promoter and Functions as a Negative Regulatory Factor that Is Inhibited by the HIV-1 Tat Protein
de la Vega, L., Sánchez‐Duffhues, G., Fresno, M., Schmitz, M. L., Muñóz, E., & Calzado, M. A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.075 · Cited by 8
Decoding molecular recognition of inhibitors targeting HDAC2 via molecular dynamics simulations and configurational entropy estimation
Tateing, S., & Suree, N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273265 · Cited by 7
Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting “block and lock” treatment strategies
Horvath, R. M., Brumme, Z. L., & Sadowski, I. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01072-23 · Cited by 7
Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal
Cisneros, W. J., Soliman, S. H. A., Walter, M., Simons, L. M., Cornish, D., Fabritiis, S. D., Halle, A. W. T., Kim, E., Wolinsky, S. M., Lorenzo-Redondo, R., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012083 · Cited by 6
Therapeutics Targeting Protein Acetylation Perturb Latency of Human Viruses
Conrad, R. J., & Ott, M. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00999 · Cited by 7
The HIV-2 OGH double reporter virus shows that HIV-2 is less cytotoxic and less sensitive to reactivation from latency than HIV-1 in cell culture
Bruggemans, A., Vansant, G., de Velde, P. V., & Debyser, Z. (2023) · Journal of Virus Eradication · doi:10.1016/j.jve.2023.100343 · Cited by 7
Studying HIV latency by modeling the interaction between HIV proteins and the innate immune response
Aguilera, L. U., & Rodríguez-González, J. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.06.025 · Cited by 7
Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis
Read, D. F., Atindaana, E., Pyaram, K., Yang, F., Emery, S. B., Cheong, A., Nakama, K. R., Burnett, C., Larragoite, E. T., Battivelli, E., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007903 · Cited by 6
Self-citation
Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene
Hamann, M. V., Ehmele, P., Verdikt, R., Bialek-Waldmann, J. K., Virdi, S., Günther, T., Lint, C. M. V., Grundhoff, A. T., Hauber, J., & Lange, U. C. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198260 · Cited by 6
FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat
Yang, X., Zhao, X., Zhu, Y., Shen, Y., Wang, Y., Lu, P., Jiang, Z., Pan, H., Yang, J., Xun, J., et al. (2021) · mBio · doi:10.1128/mbio.00795-21 · Cited by 7
Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses
Bose, D., Gagnon, J., & Chebloune, Y. (2015) · Veterinary Sciences · doi:10.3390/vetsci2040293 · Cited by 7
Topological Heterogeneity of Protein Kinase C Modulators in Human T-Cells Resolved with In-Cell Dynamic Nuclear Polarization NMR Spectroscopy
Overall, S. A., Hartmann, S. J., Luu-Nguyen, Q. H., Judge, P. T., Pinotsi, D., Marti, L., Sigurdsson, S. T., Wender, P. A., & Barnes, A. B. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c05704 · Cited by 6
Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression
Wilhelm, E., Poirier, M., Rocha, M. D., Bédard, M., McDonald, P. P., Lavigne, P., Hunter, C. L., & Bell, B. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011821 · Cited by 6
Viral Reservoirs/Transient Infection in HIV/AIDS: Where Are We Now and Where Should We Go? Summary of the June 13–14, 2002 Think Tank Meeting
Wassef, N. M., Young, J., & Miller, R. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203764969546 · Cited by 6
Three Rules for HIV Latency: Location, Location, and Location
Ott, M., & Verdin, E. M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.016 · Cited by 6
Self-citation
Computational Modelling of Intracellular Viral Kinetics and CD4+ Cellular Population Dynamics of HIV/AIDS.
Tameru, B., Habtemariam, T., Nganwa, D., Ayanwale, L., Beyene, G., Robnett, V., & Wilson, W. (2008) · PubMed · Cited by 6
Quantifying cell fate change under different stochastic gene activation frameworks
Chen, X., Sheng, Y., Chen, L., Tang, M., & Jiao, F. (2024) · Quantitative Biology · doi:10.1002/qub2.82 · Cited by 5
Transcription of HIV-1 is heterogenous among authentic latent CD4+ T cell clones
Bittar, C., Teixeira, A. R., Oliveira, T. Y., Santos, G. S. S., Lenart, K., Fumagalli, M. J., Weymar, G. H. J., Kaczynska, A., Linden, N., Ferreira, I. A. T. M., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20251584 · Cited by 5
Breaking into HIV-1’s Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir
Jones, J. E., Gunderson, C. E., Wigdahl, B. L., & Nonnemacher, M. R. (2026) · Viruses · doi:10.3390/v18030354 · Cited by 6
Bimodal Expression Patterns, and Not Viral Burst Sizes, Predict the Effects of Vpr on HIV-1 Proviral Populations in Jurkat Cells
Atindaana, E., Kissi-Twum, A. A., Emery, S. B., Burnett, C., Pitcher, J., Visser, M., Kidd, J. M., & Telesnitsky, A. (2022) · mBio · doi:10.1128/mbio.03748-21 · Cited by 5
A new chimeric protein represses HIV-1 LTR-mediated expression by DNA methylase.
Martinez-Colom, A., Lasarte, S., Fernández-Pineda, A., Relloso, M., & Muñoz-Fernández, M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.04.007 · Cited by 7
Impact of Viral Activators and Epigenetic Regulators on HIV-1 LTRs Containing Naturally Occurring Single Nucleotide Polymorphisms
Shah, S., Pirrone, V., Alexaki, A., Nonnemacher, M. R., & Wigdahl, B. L. (2015) · BioMed Research International · doi:10.1155/2015/320642 · Cited by 5
HIV-1 Integration into Chromatin: New Insights and Future Perspectives
Lesbats, P., Lavigne, M., & Parissi, V. (2011) · Future Virology · doi:10.2217/fvl.11.84 · Cited by 7
HIV Type-1 Latency: Targeted Induction of Proviral Reservoirs
Graci, J. D., Colacino, J. M., Peltz, S. W., Dougherty, J. P., & Gu, Z. (2009) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020901900501 · Cited by 5
Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication
Jehad, M. A., Ali, L. M., Pillai, V. N., Prabhu, S. G., Mustafa, F., & Rizvi, T. A. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf066 · Cited by 5
“…of the viral genes, whereas integration in the transcriptionally silent regions (heterochromatin) may not be in favor of viral expression and may even force the virus to stay transcriptionally silent (Jordan et al. 2001 , Lewinski et al. 2006 , Einkauf et al. 2022 , Teixeira et al. 2024 ).”
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal
Moran, J. A., Ranjan, A., Hourani, R., Kim, J. T., Wender, P. A., Zack, J. A., & Marsden, M. D. (2023) · Virology · doi:10.1016/j.virol.2023.02.009 · Cited by 4
Human chromatin remodelers regulating HIV-1 transcription: a target for small molecule inhibitors
Ma, Y., Li, C., & Valente, S. T. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-025-00582-w · Cited by 4
Evolution of the HIV-1 integration site landscape and inducible reservoir in early-treated people
Struyve, T., Pardons, M., Clercq, J. D., Termote, L., Lambrechts, L., Noppe, Y., Lichterfeld, M. D., Rutsaert, S., & Vandekerckhove, L. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013702 · Cited by 5
“cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies”
Cafaro, A., Sgadari, C., Picconi, O., Tripiciano, A., Moretti, S., Francavilla, V., Cossut, M. R. P., Buttò, S., Cozzone, G., Ensoli, F., et al. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1418666 · Cited by 4
Decoding Human Genome Regulatory Features That Influence HIV-1 Proviral Expression and Fate Through an Integrated Genomics Approach
Ruess, H., Lee, J., Guzman, C., Malladi, V. S., & D’Orso, I. (2022) · Bioinformatics and Biology Insights · doi:10.1177/11779322211072333 · Cited by 6
Molecular mechanisms by which the HIV-1 latent reservoir is established and therapeutic strategies for its elimination
Chvatal‐Medina, M., López-Guzmán, C., Díaz, F. J., Gallego-Quintero, S., Rugeles, M. T., & Taborda, N. A. (2023) · Archives of Virology · doi:10.1007/s00705-023-05800-y · Cited by 4
HIV-1 active and latent infections induce disparate chromatin reorganization and transcriptional regulation of mRNAs and lncRNAs in SupT1 cells
Lê-Bury, G., Chen, Y., Rhen, J. M., Grenier, J. K., Singhal, A., Russell, D. G., & Boliar, S. (2023) · mBio · doi:10.1128/mbio.02619-23 · Cited by 4
Single-cell RNA sequencing reveals common and unique gene expression profiles in primary CD4+ T cells latently infected with HIV under different conditions
Zhang, X., Qazi, A. A., Deshmukh, S., Ventura, R. L., Mukim, A., & Beliakova‐Bethell, N. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1286168 · Cited by 4
Single-virus tracking uncovers the missing link between HIV integration site location and viral gene expression
Ciuffi, A., Cristinelli, S., & Rato, S. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3358 · Cited by 4
Turning up the heat on HIV-1
Chen, I. P., & Ott, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010212117 · Cited by 4
HIV-1 expression is heterogeneous among clones of CD4+ T cells carrying authentic intact latent provirusesPreprint
Bittar, C., Teixeira, A. R., Oliveira, T. Y., Santos, G. S. S., Lenart, K., Fumagalli, M. J., Linden, N., Ferreira, I. A. T. M., Caskey, M. F., Jones, R. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.05.668730 · Cited by 4
The influence of HIV sense and antisense transcripts on stochastic HIV transcription and reactivation
Więcek, K., Wiśniewski, J., & Chen, H. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.08.003 · Cited by 3
Extracellular condensates (ECs) are endogenous modulators of HIV transcription and latency reactivation
Naushad, W., Premadasa, L. S., Tallapaneni, V., Okeoma, B. C., Chaudhary, A., Stapleton, J. T., Mohan, M., & Okeoma, C. M. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03354-w · Cited by 3
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells
Dimapasoc, M., Moran, J. A., Cole, S., Ranjan, A., Hourani, R., Kim, J. T., Wender, P. A., Marsden, M. D., & Zack, J. A. (2024) · Pathogens and Immunity · doi:10.20411/pai.v9i1.673 · Cited by 3
HIV gene expression from intact proviruses positioned in bacterial artificial chromosomes at integration sites previously identified in latently infected T cells
Eipers, P. G., Salazar-Gonzalez, J. F., & Morrow, C. D. (2010) · Virology · doi:10.1016/j.virol.2010.11.001 · Cited by 3
Molecular Biology of HIV: Implications for New Therapies
Greene, W. C., & Peterlin, B. M. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2882-6.50007-1 · Cited by 3
μ-Lat: a high-throughput humanised mouse model of latent HIV infection
Sperber, H. S., Togarrati, P. P., Raymond, K. A., Bouzidi, M. S., Gilfanova, R., Gutierrez, A. G., Muench, M. O., & Pillai, S. K. (2019) · The FASEB Journal · doi:10.1096/fj.202001612rr · Cited by 4
AIDS Gene Therapy: A Vector Able to Selectively Destroy Latently HIV‐1‐infected Cells
Váquez, F. L., & Oya, R. (2005) · doi:10.1002/9783527620982.ch22 · Cited by 3
Correction: Yeast Genetic Analysis Reveals the Involvement of Chromatin Reassembly Factors in Repressing HIV-1 Basal Transcription
Vanti, M., Gallastegui, E., Respaldiza, I., Rodríguez‐Gil, A., Gómez-Herreros, F., Jimeno-González, S., Jordan, A., & Chávez, S. (2009) · PLoS Genetics · doi:10.1371/annotation/45587774-5d7c-4023-97b0-96833be7ad9a · Cited by 3
Self-citation
Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal
Maikoo, S., Palstra, R.-J. T. S., Dong, K. L., Mahmoudi, T., Ndung’u, T., & Madlala, P. (2024) · Journal of Virus Eradication · doi:10.1016/j.jve.2024.100575 · Cited by 2
From network biology to immunity: potential longitudinal biomarkers for targeting the network topology of the HIV reservoir
Chen, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06919-z · Cited by 2
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1
Freeman, M. L., Clagett, B. M., Leskov, K., Moisi, D. D., Yendewa, G. A., Sieg, S. F., Laird, G. M., Karn, J., Jacobson, J. M., Rodriguez, B. A., et al. (2025) · Science Advances · doi:10.1126/sciadv.aea4268 · Cited by 2
The Differentially Regulated Cousins: Insights into the Differences in Transcriptional Regulatory Mechanisms Between HTLV-1 and HIV-1
Reda, O., & Satou, Y. (2026) · Viruses · doi:10.3390/v18010140 · Cited by 2
Rigorous Process for Isolation of Gut-Derived Extracellular Vesicles (EVs) and the Effect on Latent HIV
Anyanwu, N. C. J., Premadasa, L. S., Naushad, W., Okeoma, B. C., Mohan, M., & Okeoma, C. M. (2025) · Cells · doi:10.3390/cells14080568 · Cited by 2
Single-cell analysis of HIV expression and integration sites reveals robust viral expression across diverse chromatin environments
Ma, Y., Peterson, J. J., Margolis, D. M., & Browne, E. P. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00670-26 · Cited by 2
Lost in Transcription: Molecular Mechanisms that Control
Taube, R., Peterlin, B. M., Segal, S., & Russell, R. L. (2013) · Cited by 2
Nuclear Pore Complexes, Genome Organization and HIV-1 Infection
Nunzio, F. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-71614-5_8 · Cited by 2

Authors: Jordan, A., Defechereux, P., & Verdin, E.
Affiliations: University of California, San Francisco (US)
Corresponding author: Verdin, Eric
ORCID: Jordan, Albert
Verdin, Eric
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 2001-04-02
Volume: 20
Issue: 7
Pages: 1726-1738
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1093/emboj/20.7.1726
PMC: PMC145503
OpenAlex: W1964660012
Cited by: 467
References: 48
Citations by year: 2026: 13 · 2025: 21 · 2024: 19 · 2023: 18 · 2022: 15 · 2021: 15 · 2020: 21 · 2019: 21 · 2018: 20 · 2017: 26 · 2016: 25 · 2015: 27 · 2014: 14 · 2013: 15 · 2012: 14
FWCI: 6.25
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Belgian American Educational Foundation
National Institutes of Health
National Institute of General Medical Sciences (GM51671-05A2, R01GM051671)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: Tat transactivation, basal transcription, chromatin environment, HIV-1 promoter, retroviral vectors, Jurkat cells, DNA methylation, histone acetylation, HIV gene expression
MeSH terms: Binding Sites, Cell Line, Transformed, Genetic Vectors, HeLa Cells, Humans, Hydroxamic Acids, Promoter Regions, Genetic, Tetradecanoylphorbol Acetate, Transcription, Genetic, HIV-1, Transcriptional Activation, Gene Products, tat, Genome, Human, Gene Expression Regulation, Viral, HIV Long Terminal Repeat, Virus Integration, Cyclin-Dependent Kinases, Jurkat Cells, DNA Methylation, Cyclin-Dependent Kinase 9, tat Gene Products, Human Immunodeficiency Virus, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks